Рак молочної залози (стр. 35 )

179 Goodwin P), Leszcz M, Ennis M, Koopmans J, Vincent L, Guther H, et al The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001;345(24):1719-26.

180 Edmonds CV, Lockwood GA, Cunningham Al. Psychological response to long-term group therapy: a randomized trial with metastatic breast cancer patients. Psychoocology. 1999;8(1):74-91.

181 Simpson )S, Carlson LE. Trew ME Effect of group therapy for breast cancer on healthcare utilization. Cancer Pract. 20Q1;9fl):19-26.

182 Edelman S, Bell DR, Kidman AD. GroupCBT versus supportive therapy with patients who have primary breast cancer. j Cognitive Psychother 1999;13(3):189-202.

183 Edelman S, Bell DR, Kidman AD. A group Cognitive Behaviour Therapy programme with metastatic breast cancer patients. Psychooncology 1999:8(41:295-305

184 Kissane DW, Bloch S, Smith GC, Miach P, Clarke DM, Ikin). Cognitive-Existential Group Psychotherapy for women with primary breast cancer: a randomised controlled trial Psychooncology, 20Q3;12(6):532-46

185 Rustoen T, Wiklund I, Hanestad 8R, Mourn T. Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients. Cancer Nurs. 1998;21(4):235-45.

186 Meyer T), Mark, MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized controlled experiments. Health Psychol. 1995:14:101-8.

187 Greer S, Moorey 5, Baruch |D, Watson M, Robertson BM, Mason A, et al. Adjuvant psychological therapy for patients with cancer: a prospective randomized trial. 1992;BM), 304: 675-80.

188 Devi ne EC, Westlake SK. The effects of psychoeducationa I interventions provided to adults with cancer: Meta analysis of 116 studies. Oncol Nurs Forum 1995;22(9):1369-81.

189 Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS. Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J Consult Clin Psychol 2003;71:1036-48.

190 Morrow GR, Dobkm PL. Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: prevalence, etiology and behavioural interventions. Clin Psychol Rev 1988;8:517-56.

191 Burish, TG, Smyder, SL, Jenkins RA. Preparing patients for cancer chemotherapy: effect of coping preparation and rebxation interventions. Jf Consult Clin Psychol 1991 ;59.518-25.

192 Allen SM, Shah AC, Nezu AM, Nezu CM, Ciambrone D, Hogan J. el al. A problem-solving approach to stress reduction among younger women with breast carcinoma: randomized controlled trial. Cancer 2002;94(12): 3089-100

193 Gustafson DH, Hawkins R, Pingree S, McTavish f, Arora NK, Mendenhalt J, et al. Effect of computer support on younger women with breast cancer. J Gen Intern Med»2001;16f7):435-45.

194 Rawl SM, Given BA, Given CW, Champion VL, Kozachik SL, Kozachik SL, et al. Intervention to improve psychological functioning for newly diagnosed patients with cancer. Oncol Nurs Forum. 2Q02,29(6):967-75.

195 Sandgren AK. McCaul KD, King 8, O'Donnell S, Foreman G. Telephone therapy for patients with breast cancer. Oncol Nurs Forum. 2QQO;27(4):683-8.

196 Newell SA, Sanson-Fisher RW, Savolainen Nj. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research.) Natl Cancer Inst. 2002;94{S):S58-84.

197 McPherson CJ, Higgmson I), Hearn ). Effective methods of giving information in cancer" a systematic literature review of randomized controlled trials. J Public Health Med. 2001;23(3):227-34.

198 Deadman JM, Leinster SJ, Owens RG, Dewey ME, Slade PD. Taking responsibility for cancer treatment. Soc Sci Med. 2001;53(5):669-77.

199 Kissane DW. Burke 5. Psychosocial support for breast cancer patients provided by members of the treatment team: a summary of the literature 1976-1996. King's Cross(NSW);NHMRC National Breast Cancer Centre: 1996 [cited 12 July 2005] Available from URL: http://www. nbcc. org. au/bestpractice/resou rces/MTT_psychosocialsupport. pdf

200 Faftawfield Lf. Hall A. Maguire P. Baum M. A'Hern RP. A question of choice: results of a prospective 3 year follow up study of women with breast cancer. Breast 1994;3(4):202-8.

201 Sepucha KR. Belkora! K, Mutchnick S, Esserman LJ. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians.) Clin Oncol. 2002;20(11):2695-7QQ.

202 Bruera E, Sweeney C, Wrlfey J, Palmer JL, Tolley S, Rosales M, et al. Breast cancer patient perception of the helpfulness of a prompt sheet versus a general information sheet during outpatient consultation: A randomized, controlled trial j Pain Symptom Manage. 20Q3;25(5):412-9.

203 Whelan T, Sawka C, Levine M, Gafni A, Reyno L, Willan A, et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer.[comment]. J Natl Cancer Inst. 2003;16;95(8):581-7.

204 Fellowes D, Wilkinson S, Moore munication skills training for health care professionals working with cancer patients, their families and/or carers (Ccchrane Review). In: The Cochrane Library, Issue 2, 2003. Oxford;Update Software

205 Rojas MP, Telaro E, Russo A, Moschetti I. Coe L, Fossati R, et at. Follow-up strategies for women treated for early breast cancer (Cochrane Review). In: The Cochrane Library, Issue 4, 2004. Oxford, Update Software.

206 Grunfeid E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart |, Fitzpatrick R, Vessey M. Routine follow up of breast cancer in primary care: randomised trial. British Medical Journal 1996;313(7058):665-9.

207 Gulliford T, Opomo M, Wilson E, Hanham I, Epstein R. Popularity of less frequent follow-up for breast cancer in randomised study: initial findings from the hotline study. British Medical Journal 1997;314:171-7.

208 Brown L, Payne S, Royle G. Patient initiated follow up of breast cancer. Psychooncology 2002:11:346-55.

209 Grunfeid E, Noorani H, McGahan L, Paszat L, Coyle D, van Walraven C, et rveillance mammography after treatment of primary breast cancer: a systematic review. Breast 2002;! 1 (3):228-35.

210 Flobbe K, van der Linden ES, Kessels AC, van Engelshoven JM. Diagnostic value of radiological breast imaging in a non-screening population. IntJCancer. 2001;92(4):6l6-8.

211 Clinical Standards Board for Scotland. Clinical Standards: Specialist Palliative Care. Rev ed. Edinburgh;Clinica! Standards Board for Scotland:2002. [cited 12 July 2005] Available from URL: httpV/www. nh5healthquality. org/nhsqi5/filesfiPC. pdf

212 Scottish Intercollegiate Guidelines Network (SIGN) Control of pain in patients with cancer. Edinburgh:SIGN; 2000. (SIGN guideline no.44). [cited 12 July 2QD5] Available from URL: http://www. sign. ac. uk/pdf/ sign44.pdf

213 HeamJ. HigginsonlJ. DospecialistpalliativecaretEamsimproveoutcomes for cancer patients? A systematic literature review. PalliatMed. 1998,12(5): 317-32.

214 Homsi J, Walsh D, Nelson KA, LeGrand SB, Davis M, Khawarn E, et al. The impact of a palliative medicine consultation service in medical pport Care Cancer. 2Q02;1Q(4):337-42.

215 F. Cardoso, E. Senkus-Konefka, L. Fallowfield, A. Costa & M. Castiglione. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology 21 (Supplement 5): v9–v14, 2010

doi:10.1093/annonc/mdq159 http://www. esmo. org/education/practice-tools. html

216 S. Aebi1, T. Davidson, G. Gruber & M. Castiglione Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology 21 (Supplement 5): v9–v14, 2010 http://www. esmo. org/education/practice-tools. html

217 J. Balmana, O. Diez, I. Rubio & M. Castiglione BRCA in breast cancer: ESMO Clinical Practice Guidelines Annals of Oncology 21 (Supplement 5): v20–v22, 2010 http://www. esmo. org/education/practice-tools. html

218 Advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer. NGC:007179 AHRQ (US) - Agency for Healthcare Research and Quality Feb 01, 2009.

219 amilial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (partial update of CG14) (CG41) NICE (GB) - National Institute for Health and Clinical Excellence Oct 01, 2006

220 Early and locally advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer. NGC:007180 AHRQ (US) - Agency for Healthcare Research and Quality Feb 01, 2009.

221 Management of Early Breast Cancer NZGG (NZ) - New Zealand Guidelines Group Aug 01, 2009.

СПИСОК ЛіТЕРАТУРи, використанИЙ В ПРОЦЕСІ АДАПТАЦІЇ клінічної настанови

1.  SIGN Guideline 84: Breast Cancer in Women (2005).

2.  SIGN Guideline 29: Breast Cancer in Women (1998)

3.  NICE Clinical Guideline update CG 041: Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (partial update of CG 14)

4.  NICE clinical guideline 164 Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer, 2013

5.  Advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer. Feb 01, 2009.

6.  Early and locally advanced breast cancer. Diagnosis and treatment. National Collaborating Centre for Cancer. Feb 01, 2009. 222

7.  ESO - ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) August 2014

8.  Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA 3rd. Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol. 2014 Apr;25(4):808-15. doi: 10.1093/annonc/mdu009. Epub 2014 Mar 10.

9.  Yardley DA, Noguchi S, Pritchard KI, Burris HA 3rd, Baselga J, Gnant M, Hortobagyi GN, Campone M, Pistilli B, Piccart M, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Feng W, Cahana A, Taran T, Lebwohl D, Rugo HS. Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis. Adv Ther. 2013 Oct;30(10):870-84. doi: 10.1007/s12325-013-0060-1. Epub 2013 Oct 25.